Clinical Trials Directory

Trials / Completed

CompletedNCT01319123

Evaluate the Impact of Drawtex in Venous Leg Ulcers

Clinical Study to Comparatively Evaluate the Impact of Drawtex Wound Dressing Against Wound Bioburden in Moderately to Highly Exuding Venous Leg Ulcers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Southwest Regional Wound Care Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a clinical study to comparatively evaluate the impact of Drawtex wound dressing against wound bioburden in moderately to highly exuding venous leg ulcers.

Detailed description

Each subject is expected to participate in this study for a period of four weeks or until reepithelialization, whichever occurs first. Subjects may participate for an additional period of four weeks or until reepithelialization, whichever occurs first: this it to be decided by the investigator and will be determined by the accessibility of the patient (physical location) and the suitability of the wound to further treatment. The maximum time period for the study is 8 weeks. The minimum time frame is at least 4 week, or until reepithelialization occurs.

Conditions

Interventions

TypeNameDescription
DEVICEDrawtex dressingThe dressing is indicated for moderately to heavily exuding wounds such as venous leg ulcers

Timeline

Start date
2010-10-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2011-03-21
Last updated
2012-10-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01319123. Inclusion in this directory is not an endorsement.